Furthermore, it has been shown that peroxisome proliferator-activated receptor γ (PPARγ) inhibits the expression of GPR132 proteins in macrophages, so targeting the lactate-PPARγ/GPR132 receptor-related pathway may have an inhibitory effect on the pro-tumor effects of TAMs [121]. The gene discussed is GPR132; the disease is neoplasm.